Form 8-K - Current report:
SEC Accession No. 0001104659-25-044352
Filing Date
2025-05-05
Accepted
2025-05-05 07:27:31
Documents
17
Period of Report
2025-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513694d1_8k.htm   iXBRL 8-K 36020
2 EXHIBIT 99.1 tm2513694d1_ex99-1.htm EX-99.1 110181
3 EXHIBIT 99.2 tm2513694d1_ex99-2.htm EX-99.2 18109
4 GRAPHIC tm2513694d1_ex99-1img01.jpg GRAPHIC 2056
5 GRAPHIC tm2513694d1_ex99-2img01.jpg GRAPHIC 2169
  Complete submission text file 0001104659-25-044352.txt   365299

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA twst-20250502.xsd EX-101.SCH 3035
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20250502_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20250502_pre.xml EX-101.PRE 22372
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2513694d1_8k_htm.xml XML 3553
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 25910916
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)